Filing Details

Accession Number:
0001209191-14-007972
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-06 15:44:42
Reporting Period:
2014-02-04
Filing Date:
2014-02-06
Accepted Time:
2014-02-06 15:44:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305253 Celladon Corp CLDN Biological Products, (No Disgnostic Substances) (2836) 330971591
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591045 Johan Kordel 12760 High Bluff Drive, Ste 240
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-04 1,544,397 $0.00 1,544,397 No 4 C Indirect Lundbeckfond Invest A/S
Common Stock Acquisiton 2014-02-04 18,605 $8.00 1,563,002 No 4 C Indirect Lundbeckfond Invest A/S
Common Stock Acquisiton 2014-02-04 182,681 $8.00 1,745,683 No 4 P Indirect Lundbeckfond Invest A/S
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Lundbeckfond Invest A/S
No 4 C Indirect Lundbeckfond Invest A/S
No 4 P Indirect Lundbeckfond Invest A/S
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Convertible Preferred Stock Disposition 2014-02-04 19,289,531 $0.00 1,544,397 $0.00
Common Stock Convertible Promissory Notes Disposition 2014-02-04 18,605 $8.00 18,605 $8.00
Series A-1 Preferred Stock Series A-1 Preferred Warrants Disposition 2014-02-04 358,049 $0.00 358,049 $0.45
Common Stock Common Warrants Acquisiton 2014-02-04 28,666 $0.00 28,666 $5.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 2013-10-15 2018-10-15 No 4 C Indirect
28,666 2013-10-15 2018-10-15 No 4 C Indirect
Footnotes
  1. Every 12.49 shares of Series A-1 Preferred Stock automatically converted into 1 share of Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  2. Shares held by Lundbeckfond Invest A/S. The Reporting Person shares voting and investment power with respect to the shares held by Lundbeckfond Invest A/S and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
  3. Automatic conversion, in connection with the Issuer's initial public offering, of convertible promissory notes, including principal and accrued interest.
  4. The shares were purchased at the Issuer's initial public offering.
  5. Represents the automatic conversion of Series A-1 Preferred Warrants into Common Stock Warrants on a 1-for-12.49 basis upon the closing of the Issuer's initial public offering.